Summary

The global In Vitro Permeation Testing (IVPT) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
In Vitro Permeation Testing (IVPT) is a test method used to evaluate the permeability of drugs, cosmetics or other substances through the skin. This test simulates human skin and evaluates the rate and extent to which a specific substance penetrates the skin under specific conditions. This test is usually performed in a laboratory setting using a skin model to simulate real skin. These skin models can be artificial or derived from skin tissue from animals (such as mice or guinea pigs) or humans. The test sample is usually applied to the surface of a skin model in some form (such as a solution, gel or emulsion) and its permeation properties are then evaluated by monitoring the penetration of substances in the sample.
In 2025, the North America In Vitro Permeation Testing (IVPT) market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of In Vitro Permeation Testing (IVPT) include Charles River Laboratories, Xenometrix, Intertek, Eurofins, Tergus Pharma, SGS, Nelson Labs, Revivo BioSystems, Stira Pharmaceuticals, Raptim Research, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global In Vitro Permeation Testing (IVPT) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Charles River Laboratories
Xenometrix
Intertek
Eurofins
Tergus Pharma
SGS
Nelson Labs
Revivo BioSystems
Stira Pharmaceuticals
Raptim Research
MedPharm
CPL
Diteba
Topical Products Testing
InVitro Research Solutions
Nuvisan
QPS
CD Formulation
Sun-Novo
Frontage
Mingjie Pharmaceutical
Porton
Segment by Type
Development and Validation of New IVPT Analysis Methods
Adaptation and Optimization of Existing IVPT Methods
Skin Integrity Testing
Bioequivalence (BE) of Generic Drugs
Segment by Application
Pharmaceuticals
Agrochemical/Chemical
Cosmetics
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of In Vitro Permeation Testing (IVPT) market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the In Vitro Permeation Testing (IVPT) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Development and Validation of New IVPT Analysis Methods
1.2.3 Adaptation and Optimization of Existing IVPT Methods
1.2.4 Skin Integrity Testing
1.2.5 Bioequivalence (BE) of Generic Drugs
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceuticals
1.3.3 Agrochemical/Chemical
1.3.4 Cosmetics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global In Vitro Permeation Testing (IVPT) Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Region (2021-2026)
2.4 Global In Vitro Permeation Testing (IVPT) Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America In Vitro Permeation Testing (IVPT) Market Size and Prospective (2021-2032)
2.5.2 Europe In Vitro Permeation Testing (IVPT) Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific In Vitro Permeation Testing (IVPT) Market Size and Prospective (2021-2032)
2.5.4 Latin America In Vitro Permeation Testing (IVPT) Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa In Vitro Permeation Testing (IVPT) Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global In Vitro Permeation Testing (IVPT) Historical Market Size by Type (2021-2026)
3.2 Global In Vitro Permeation Testing (IVPT) Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of In Vitro Permeation Testing (IVPT)

4 Breakdown Data by Application
4.1 Global In Vitro Permeation Testing (IVPT) Historical Market Size by Application (2021-2026)
4.2 Global In Vitro Permeation Testing (IVPT) Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in In Vitro Permeation Testing (IVPT) Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top In Vitro Permeation Testing (IVPT) Players by Revenue (2021-2026)
5.1.2 Global In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by In Vitro Permeation Testing (IVPT) Revenue
5.4 Global In Vitro Permeation Testing (IVPT) Market Concentration Analysis
5.4.1 Global In Vitro Permeation Testing (IVPT) Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by In Vitro Permeation Testing (IVPT) Revenue in 2025
5.5 Global Key Players of In Vitro Permeation Testing (IVPT) Head Offices and Areas Served
5.6 Global Key Players of In Vitro Permeation Testing (IVPT), Product and Application
5.7 Global Key Players of In Vitro Permeation Testing (IVPT), Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America In Vitro Permeation Testing (IVPT) Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America In Vitro Permeation Testing (IVPT) Market Size by Type (2021-2026)
6.1.2.2 North America In Vitro Permeation Testing (IVPT) Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America In Vitro Permeation Testing (IVPT) Market Size by Application (2021-2026)
6.1.3.2 North America In Vitro Permeation Testing (IVPT) Market Share by Application (2021-2026)
6.1.4 North America In Vitro Permeation Testing (IVPT) Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe In Vitro Permeation Testing (IVPT) Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe In Vitro Permeation Testing (IVPT) Market Size by Type (2021-2026)
6.2.2.2 Europe In Vitro Permeation Testing (IVPT) Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe In Vitro Permeation Testing (IVPT) Market Size by Application (2021-2026)
6.2.3.2 Europe In Vitro Permeation Testing (IVPT) Market Share by Application (2021-2026)
6.2.4 Europe In Vitro Permeation Testing (IVPT) Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific In Vitro Permeation Testing (IVPT) Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific In Vitro Permeation Testing (IVPT) Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific In Vitro Permeation Testing (IVPT) Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific In Vitro Permeation Testing (IVPT) Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific In Vitro Permeation Testing (IVPT) Market Share by Application (2021-2026)
6.3.4 Asia-Pacific In Vitro Permeation Testing (IVPT) Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America In Vitro Permeation Testing (IVPT) Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America In Vitro Permeation Testing (IVPT) Market Size by Type (2021-2026)
6.4.2.2 Latin America In Vitro Permeation Testing (IVPT) Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America In Vitro Permeation Testing (IVPT) Market Size by Application (2021-2026)
6.4.3.2 Latin America In Vitro Permeation Testing (IVPT) Market Share by Application (2021-2026)
6.4.4 Latin America In Vitro Permeation Testing (IVPT) Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa In Vitro Permeation Testing (IVPT) Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa In Vitro Permeation Testing (IVPT) Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa In Vitro Permeation Testing (IVPT) Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa In Vitro Permeation Testing (IVPT) Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa In Vitro Permeation Testing (IVPT) Market Share by Application (2021-2026)
6.5.4 Middle East & Africa In Vitro Permeation Testing (IVPT) Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 Charles River Laboratories
7.1.1 Charles River Laboratories Company Details
7.1.2 Charles River Laboratories Business Overview
7.1.3 Charles River Laboratories In Vitro Permeation Testing (IVPT) Introduction
7.1.4 Charles River Laboratories Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.1.5 Charles River Laboratories Recent Development
7.2 Xenometrix
7.2.1 Xenometrix Company Details
7.2.2 Xenometrix Business Overview
7.2.3 Xenometrix In Vitro Permeation Testing (IVPT) Introduction
7.2.4 Xenometrix Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.2.5 Xenometrix Recent Development
7.3 Intertek
7.3.1 Intertek Company Details
7.3.2 Intertek Business Overview
7.3.3 Intertek In Vitro Permeation Testing (IVPT) Introduction
7.3.4 Intertek Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.3.5 Intertek Recent Development
7.4 Eurofins
7.4.1 Eurofins Company Details
7.4.2 Eurofins Business Overview
7.4.3 Eurofins In Vitro Permeation Testing (IVPT) Introduction
7.4.4 Eurofins Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.4.5 Eurofins Recent Development
7.5 Tergus Pharma
7.5.1 Tergus Pharma Company Details
7.5.2 Tergus Pharma Business Overview
7.5.3 Tergus Pharma In Vitro Permeation Testing (IVPT) Introduction
7.5.4 Tergus Pharma Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.5.5 Tergus Pharma Recent Development
7.6 SGS
7.6.1 SGS Company Details
7.6.2 SGS Business Overview
7.6.3 SGS In Vitro Permeation Testing (IVPT) Introduction
7.6.4 SGS Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.6.5 SGS Recent Development
7.7 Nelson Labs
7.7.1 Nelson Labs Company Details
7.7.2 Nelson Labs Business Overview
7.7.3 Nelson Labs In Vitro Permeation Testing (IVPT) Introduction
7.7.4 Nelson Labs Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.7.5 Nelson Labs Recent Development
7.8 Revivo BioSystems
7.8.1 Revivo BioSystems Company Details
7.8.2 Revivo BioSystems Business Overview
7.8.3 Revivo BioSystems In Vitro Permeation Testing (IVPT) Introduction
7.8.4 Revivo BioSystems Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.8.5 Revivo BioSystems Recent Development
7.9 Stira Pharmaceuticals
7.9.1 Stira Pharmaceuticals Company Details
7.9.2 Stira Pharmaceuticals Business Overview
7.9.3 Stira Pharmaceuticals In Vitro Permeation Testing (IVPT) Introduction
7.9.4 Stira Pharmaceuticals Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.9.5 Stira Pharmaceuticals Recent Development
7.10 Raptim Research
7.10.1 Raptim Research Company Details
7.10.2 Raptim Research Business Overview
7.10.3 Raptim Research In Vitro Permeation Testing (IVPT) Introduction
7.10.4 Raptim Research Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.10.5 Raptim Research Recent Development
7.11 MedPharm
7.11.1 MedPharm Company Details
7.11.2 MedPharm Business Overview
7.11.3 MedPharm In Vitro Permeation Testing (IVPT) Introduction
7.11.4 MedPharm Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.11.5 MedPharm Recent Development
7.12 CPL
7.12.1 CPL Company Details
7.12.2 CPL Business Overview
7.12.3 CPL In Vitro Permeation Testing (IVPT) Introduction
7.12.4 CPL Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.12.5 CPL Recent Development
7.13 Diteba
7.13.1 Diteba Company Details
7.13.2 Diteba Business Overview
7.13.3 Diteba In Vitro Permeation Testing (IVPT) Introduction
7.13.4 Diteba Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.13.5 Diteba Recent Development
7.14 Topical Products Testing
7.14.1 Topical Products Testing Company Details
7.14.2 Topical Products Testing Business Overview
7.14.3 Topical Products Testing In Vitro Permeation Testing (IVPT) Introduction
7.14.4 Topical Products Testing Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.14.5 Topical Products Testing Recent Development
7.15 InVitro Research Solutions
7.15.1 InVitro Research Solutions Company Details
7.15.2 InVitro Research Solutions Business Overview
7.15.3 InVitro Research Solutions In Vitro Permeation Testing (IVPT) Introduction
7.15.4 InVitro Research Solutions Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.15.5 InVitro Research Solutions Recent Development
7.16 Nuvisan
7.16.1 Nuvisan Company Details
7.16.2 Nuvisan Business Overview
7.16.3 Nuvisan In Vitro Permeation Testing (IVPT) Introduction
7.16.4 Nuvisan Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.16.5 Nuvisan Recent Development
7.17 QPS
7.17.1 QPS Company Details
7.17.2 QPS Business Overview
7.17.3 QPS In Vitro Permeation Testing (IVPT) Introduction
7.17.4 QPS Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.17.5 QPS Recent Development
7.18 CD Formulation
7.18.1 CD Formulation Company Details
7.18.2 CD Formulation Business Overview
7.18.3 CD Formulation In Vitro Permeation Testing (IVPT) Introduction
7.18.4 CD Formulation Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.18.5 CD Formulation Recent Development
7.19 Sun-Novo
7.19.1 Sun-Novo Company Details
7.19.2 Sun-Novo Business Overview
7.19.3 Sun-Novo In Vitro Permeation Testing (IVPT) Introduction
7.19.4 Sun-Novo Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.19.5 Sun-Novo Recent Development
7.20 Frontage
7.20.1 Frontage Company Details
7.20.2 Frontage Business Overview
7.20.3 Frontage In Vitro Permeation Testing (IVPT) Introduction
7.20.4 Frontage Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.20.5 Frontage Recent Development
7.21 Mingjie Pharmaceutical
7.21.1 Mingjie Pharmaceutical Company Details
7.21.2 Mingjie Pharmaceutical Business Overview
7.21.3 Mingjie Pharmaceutical In Vitro Permeation Testing (IVPT) Introduction
7.21.4 Mingjie Pharmaceutical Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.21.5 Mingjie Pharmaceutical Recent Development
7.22 Porton
7.22.1 Porton Company Details
7.22.2 Porton Business Overview
7.22.3 Porton In Vitro Permeation Testing (IVPT) Introduction
7.22.4 Porton Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026)
7.22.5 Porton Recent Development

8 In Vitro Permeation Testing (IVPT) Market Dynamics
8.1 In Vitro Permeation Testing (IVPT) Industry Trends
8.2 In Vitro Permeation Testing (IVPT) Market Drivers
8.3 In Vitro Permeation Testing (IVPT) Market Challenges
8.4 In Vitro Permeation Testing (IVPT) Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global In Vitro Permeation Testing (IVPT) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global In Vitro Permeation Testing (IVPT) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market In Vitro Permeation Testing (IVPT) Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global In Vitro Permeation Testing (IVPT) Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global In Vitro Permeation Testing (IVPT) Revenue Share by Region (2021-2026)
Table 6. Global In Vitro Permeation Testing (IVPT) Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global In Vitro Permeation Testing (IVPT) Revenue Share Forecast by Region (2027-2032)
Table 8. Global In Vitro Permeation Testing (IVPT) Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Type (2021-2026)
Table 10. Global In Vitro Permeation Testing (IVPT) Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global In Vitro Permeation Testing (IVPT) Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Application (2021-2026)
Table 15. Global In Vitro Permeation Testing (IVPT) Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in In Vitro Permeation Testing (IVPT) Applications
Table 18. Global In Vitro Permeation Testing (IVPT) Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global In Vitro Permeation Testing (IVPT) Market Share by Players (2021-2026)
Table 20. Global Top In Vitro Permeation Testing (IVPT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Permeation Testing (IVPT) as of 2025)
Table 21. Ranking of Global Top In Vitro Permeation Testing (IVPT) Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by In Vitro Permeation Testing (IVPT) Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of In Vitro Permeation Testing (IVPT), Headquarters and Area Served
Table 24. Global Key Players of In Vitro Permeation Testing (IVPT), Product and Application
Table 25. Global Key Players of In Vitro Permeation Testing (IVPT), Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America In Vitro Permeation Testing (IVPT) Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Company (2021-2026)
Table 29. North America In Vitro Permeation Testing (IVPT) Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America In Vitro Permeation Testing (IVPT) Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe In Vitro Permeation Testing (IVPT) Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Company (2021-2026)
Table 33. Europe In Vitro Permeation Testing (IVPT) Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe In Vitro Permeation Testing (IVPT) Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific In Vitro Permeation Testing (IVPT) Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific In Vitro Permeation Testing (IVPT) Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific In Vitro Permeation Testing (IVPT) Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America In Vitro Permeation Testing (IVPT) Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America In Vitro Permeation Testing (IVPT) Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America In Vitro Permeation Testing (IVPT) Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa In Vitro Permeation Testing (IVPT) Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa In Vitro Permeation Testing (IVPT) Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa In Vitro Permeation Testing (IVPT) Market Size by Application (2021-2026) & (US$ Million)
Table 47. Charles River Laboratories Company Details
Table 48. Charles River Laboratories Business Overview
Table 49. Charles River Laboratories In Vitro Permeation Testing (IVPT) Product
Table 50. Charles River Laboratories Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 51. Charles River Laboratories Recent Development
Table 52. Xenometrix Company Details
Table 53. Xenometrix Business Overview
Table 54. Xenometrix In Vitro Permeation Testing (IVPT) Product
Table 55. Xenometrix Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 56. Xenometrix Recent Development
Table 57. Intertek Company Details
Table 58. Intertek Business Overview
Table 59. Intertek In Vitro Permeation Testing (IVPT) Product
Table 60. Intertek Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 61. Intertek Recent Development
Table 62. Eurofins Company Details
Table 63. Eurofins Business Overview
Table 64. Eurofins In Vitro Permeation Testing (IVPT) Product
Table 65. Eurofins Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 66. Eurofins Recent Development
Table 67. Tergus Pharma Company Details
Table 68. Tergus Pharma Business Overview
Table 69. Tergus Pharma In Vitro Permeation Testing (IVPT) Product
Table 70. Tergus Pharma Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 71. Tergus Pharma Recent Development
Table 72. SGS Company Details
Table 73. SGS Business Overview
Table 74. SGS In Vitro Permeation Testing (IVPT) Product
Table 75. SGS Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 76. SGS Recent Development
Table 77. Nelson Labs Company Details
Table 78. Nelson Labs Business Overview
Table 79. Nelson Labs In Vitro Permeation Testing (IVPT) Product
Table 80. Nelson Labs Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 81. Nelson Labs Recent Development
Table 82. Revivo BioSystems Company Details
Table 83. Revivo BioSystems Business Overview
Table 84. Revivo BioSystems In Vitro Permeation Testing (IVPT) Product
Table 85. Revivo BioSystems Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 86. Revivo BioSystems Recent Development
Table 87. Stira Pharmaceuticals Company Details
Table 88. Stira Pharmaceuticals Business Overview
Table 89. Stira Pharmaceuticals In Vitro Permeation Testing (IVPT) Product
Table 90. Stira Pharmaceuticals Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 91. Stira Pharmaceuticals Recent Development
Table 92. Raptim Research Company Details
Table 93. Raptim Research Business Overview
Table 94. Raptim Research In Vitro Permeation Testing (IVPT) Product
Table 95. Raptim Research Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 96. Raptim Research Recent Development
Table 97. MedPharm Company Details
Table 98. MedPharm Business Overview
Table 99. MedPharm In Vitro Permeation Testing (IVPT) Product
Table 100. MedPharm Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 101. MedPharm Recent Development
Table 102. CPL Company Details
Table 103. CPL Business Overview
Table 104. CPL In Vitro Permeation Testing (IVPT) Product
Table 105. CPL Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 106. CPL Recent Development
Table 107. Diteba Company Details
Table 108. Diteba Business Overview
Table 109. Diteba In Vitro Permeation Testing (IVPT) Product
Table 110. Diteba Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 111. Diteba Recent Development
Table 112. Topical Products Testing Company Details
Table 113. Topical Products Testing Business Overview
Table 114. Topical Products Testing In Vitro Permeation Testing (IVPT) Product
Table 115. Topical Products Testing Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 116. Topical Products Testing Recent Development
Table 117. InVitro Research Solutions Company Details
Table 118. InVitro Research Solutions Business Overview
Table 119. InVitro Research Solutions In Vitro Permeation Testing (IVPT) Product
Table 120. InVitro Research Solutions Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 121. InVitro Research Solutions Recent Development
Table 122. Nuvisan Company Details
Table 123. Nuvisan Business Overview
Table 124. Nuvisan In Vitro Permeation Testing (IVPT) Product
Table 125. Nuvisan Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 126. Nuvisan Recent Development
Table 127. QPS Company Details
Table 128. QPS Business Overview
Table 129. QPS In Vitro Permeation Testing (IVPT) Product
Table 130. QPS Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 131. QPS Recent Development
Table 132. CD Formulation Company Details
Table 133. CD Formulation Business Overview
Table 134. CD Formulation In Vitro Permeation Testing (IVPT) Product
Table 135. CD Formulation Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 136. CD Formulation Recent Development
Table 137. Sun-Novo Company Details
Table 138. Sun-Novo Business Overview
Table 139. Sun-Novo In Vitro Permeation Testing (IVPT) Product
Table 140. Sun-Novo Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 141. Sun-Novo Recent Development
Table 142. Frontage Company Details
Table 143. Frontage Business Overview
Table 144. Frontage In Vitro Permeation Testing (IVPT) Product
Table 145. Frontage Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 146. Frontage Recent Development
Table 147. Mingjie Pharmaceutical Company Details
Table 148. Mingjie Pharmaceutical Business Overview
Table 149. Mingjie Pharmaceutical In Vitro Permeation Testing (IVPT) Product
Table 150. Mingjie Pharmaceutical Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 151. Mingjie Pharmaceutical Recent Development
Table 152. Porton Company Details
Table 153. Porton Business Overview
Table 154. Porton In Vitro Permeation Testing (IVPT) Product
Table 155. Porton Revenue in In Vitro Permeation Testing (IVPT) Business (2021-2026) & (US$ Million)
Table 156. Porton Recent Development
Table 157. In Vitro Permeation Testing (IVPT) Market Trends
Table 158. In Vitro Permeation Testing (IVPT) Market Drivers
Table 159. In Vitro Permeation Testing (IVPT) Market Challenges
Table 160. In Vitro Permeation Testing (IVPT) Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources

List of Figures
Figure 1. In Vitro Permeation Testing (IVPT) Product Picture
Figure 2. Global In Vitro Permeation Testing (IVPT) Market Share by Type: 2025 vs 2032
Figure 3. Development and Validation of New IVPT Analysis Methods Features
Figure 4. Adaptation and Optimization of Existing IVPT Methods Features
Figure 5. Skin Integrity Testing Features
Figure 6. Bioequivalence (BE) of Generic Drugs Features
Figure 7. Global In Vitro Permeation Testing (IVPT) Market Share by Application: 2025 vs 2032
Figure 8. Pharmaceuticals
Figure 9. Agrochemical/Chemical
Figure 10. Cosmetics
Figure 11. Others
Figure 12. In Vitro Permeation Testing (IVPT) Report Years Considered
Figure 13. Global In Vitro Permeation Testing (IVPT) Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 14. Global In Vitro Permeation Testing (IVPT) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global In Vitro Permeation Testing (IVPT) Market Share by Revenue, by Region: 2021 vs 2025
Figure 16. North America In Vitro Permeation Testing (IVPT) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Europe In Vitro Permeation Testing (IVPT) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Asia-Pacific In Vitro Permeation Testing (IVPT) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Latin America In Vitro Permeation Testing (IVPT) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Middle East & Africa In Vitro Permeation Testing (IVPT) Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Global In Vitro Permeation Testing (IVPT) Market Share by Players in 2025
Figure 22. Global Top In Vitro Permeation Testing (IVPT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Permeation Testing (IVPT) as of 2025)
Figure 23. The Top 10 and 5 Players Market Share by In Vitro Permeation Testing (IVPT) Revenue in 2025
Figure 24. North America In Vitro Permeation Testing (IVPT) Market Share by Type (2021-2026)
Figure 25. North America In Vitro Permeation Testing (IVPT) Market Share by Application (2021-2026)
Figure 26. Europe In Vitro Permeation Testing (IVPT) Market Share by Type (2021-2026)
Figure 27. Europe In Vitro Permeation Testing (IVPT) Market Share by Application (2021-2026)
Figure 28. Asia-Pacific In Vitro Permeation Testing (IVPT) Market Share by Type (2021-2026)
Figure 29. Asia-Pacific In Vitro Permeation Testing (IVPT) Market Share by Application (2021-2026)
Figure 30. Latin America In Vitro Permeation Testing (IVPT) Market Share by Type (2021-2026)
Figure 31. Latin America In Vitro Permeation Testing (IVPT) Market Share by Application (2021-2026)
Figure 32. Middle East & Africa In Vitro Permeation Testing (IVPT) Market Share by Type (2021-2026)
Figure 33. Middle East & Africa In Vitro Permeation Testing (IVPT) Market Share by Application (2021-2026)
Figure 34. Charles River Laboratories Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 35. Xenometrix Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 36. Intertek Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 37. Eurofins Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 38. Tergus Pharma Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 39. SGS Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 40. Nelson Labs Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 41. Revivo BioSystems Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 42. Stira Pharmaceuticals Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 43. Raptim Research Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 44. MedPharm Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 45. CPL Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 46. Diteba Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 47. Topical Products Testing Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 48. InVitro Research Solutions Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 49. Nuvisan Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 50. QPS Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 51. CD Formulation Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 52. Sun-Novo Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 53. Frontage Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 54. Mingjie Pharmaceutical Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 55. Porton Revenue Growth Rate in In Vitro Permeation Testing (IVPT) Business (2021-2026)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed